Strategies to Improve Drug Use

Slides:



Advertisements
Similar presentations
UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
Advertisements

Vertical versus Decentralized TB Pharmaceutical Management
Priority Issues and Strategic Information Needs for Kenya in scaling up ART.
World Health Organization
Promoting Rational Use of Injections within National Medicine Policies World Health Organisation Dept. Essential Drugs and Medicines Policy Safe Injection.
1 Figure 1: Factors affecting the quality of care Impact (change in health status) Quality of Care Supply: health system Demand: expectations and needs.
1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Promoting Rational Use of Drugs
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
Management of Medicines and Pharmaceutical Supplies for use in the prevention and treatment of Pre-eclampsia and Eclampsia Grace Adeya, SPS/MSH February.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
Belize, May31,2006 Health Systems Strengthening Seminar Monitoring Health Systems Change/Health Reforms Service provision Dr J. Gernay.
World Health Organization
Inventory Management: Distribution, ICS, LMIS Nairobi, 21 February, 2006 Yasmin Chandani HIV/AIDS Technical Coordinator.
Introducing Quality Management in District Hospitals in Tanga Region First Experiences from Korogwe District Hospital.
1 Alvimopan RiskMAP Joyce Weaver, Pharm.D., BCPS Office of Surveillance and Epidemiology.
TBS November 4, |1 | AMR and appropriate use of antimicrobials Nicola Magrini and Jane Robertson Policy, Access and Use Team, EMP TBS 4 November.
Promoting Rational Use of Drugs Krisantha Weerasuriya MD.
Entrenching the KNH Formulary to Clinical Practice DR WK SIGILAI MTC CHAIR.
Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.
IMPACT OF EDUCATIONAL INTERVENTION ON PRESCRIBING BEHAVIOUR AND COST OF THERAPY IN BRONCHIAL ASTHMA IN COLONY HOSPITALS OF DELHI Kotwani A, Gupta U, Suri.
Using Longitudinal Data for Evaluating Policy Changes and Other Interventions -Information system in Tamilnadu Medical Services Corporation.
Rational Use of Drug Ali Abad hospital April 12 th, 2005.
Strategic Decentralization: Centralizing Logistics Paula Nersesian, RN, MPH.
Accessibility of Essential Drugs in Remote Areas of Laos Sivong SENGALOUNDETH, Bounnao PHACHOMPHONH, Sivixay XAYASAN Khamveuy THAMMAKHANH, Vongchanh PHANOUVONG.
Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
Promoting Rational Use of Drugs Krisantha Weerasuriya MD.
Good Procurement Practices in National TB Programs
Strategies for Enhancing Access to Medicines Overview of Potential Strategies for Improving Access and Use David Lee.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
ACCESS TO MEDICINES - POLICY AND ISSUES
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Promoting Drug and Therapeutics Committees in the Developing World
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
Procurement &supply chain management 5 th Joint International Monitoring Mission.
Impact of a cost sharing drug supply scheme on the quality of care in public primary health care facilities in rural Nepal Kathleen Holloway Bharat Raj.
Lesotho UHC Meeting Cape Town. Take Home Points HR Infrastructure Technology and information for decision making Supply chain Governance – Cooperate.
Questions to Committee about Potential Cancer Risk with Use of Topical Immunosuppressants (Calcineurin Inhibitors) Question 1: Messages about Risk A. Based.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Lipid Lowering Drug Prescribing: ‘patchy’ guideline adherence despite multi-faceted interventions M.E. Cupples 1, Terry Bradley, Chris Hall 1 Dept General.
Learning About Drug Use1 An Overview of the Process of Changing Drug Use 1. EXAMINE Measure Existing Practices (Descriptive Quantitative Studies) 2. DIAGNOSE.
Progress on Implementation of the Comprehensive HIV and AIDS Plan February 2004.
The Law of the KR «On making amendments and changes to certain legislative acts of the KR» 4 th MeTA Forum in the Kyrgyz Republic Bishkek, December 8,
Make or Buy transport.
Rational Use of Medication And Patient Compliance
Monitoring and Evaluation Frameworks
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Procurement and Supply Management for iCCM – common challenges
WHO Medicines Work in Countries: The Kenya Example
Evaluating Australia‘s National Strategy for Quality Use of Medicines
Inter-Agency Guidelines for Good Procurement of Pharmaceuticals
INTRODUCTION OF URINE LF-LAM TEST IN SA
Richard Laing EMP/WHO TBS 2012
Trap B and Hansen EH Euro Health Group, Denmark &
Framework for Changing Drug Use Practices
Framework for Changing Drug Use Practices
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies Introduction and Overview May 30 to June 4, 2005 Abuja, Nigeria.
Managerial and Regulatory Strategies to Improve Drug Use
Issues on Dispensing Dr Percy Mahlathi.
Managerial and Regulatory Strategies to Improve Drug Use
Richard Laing WHO/PAU TBS 2013
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Access to Essential Medicines
Regulatory barriers for the circular economy
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
Strategies to Improve Drug Use
Presentation transcript:

Strategies to Improve Drug Use Educational: to inform or persuade Managerial: to structure or guide decisions Regulatory: to restrict or limit decisions Framework for Changing Drug Use Practices

Managerial Strategies 1 GOAL: to structure or guide decisions Changes in Selection, Procurement, Distribution essential drugs lists morbidity-based quantification kit system distribution Changes Aimed at Prescribers utilization review (audit) and feedback diagnostic and treatment guidelines structured drug order forms peer group monitoring Framework for Changing Drug Use Practices

Managerial Strategies 2: GOAL: to structure or guide decisions Changes Aimed at Dispensers allowing generic substitution improved labeling course of therapy packaging Changes in Economic Incentives patient cost-sharing revolving drug funds cost controls Framework for Changing Drug Use Practices

Standard Treatment Guidelines STG’s lead prescribers to most cost-effective treatments Particularly useful for low level workers Can be used for training, examinations and audit Used for procurement Framework for Changing Drug Use Practices

Prescribing Audits plus "Feedback" to Prescriber Establish Criteria & Guidelines for Review AUDIT (COLLECT DATA ON) PRESCRIBING · Comparison with Guidelines · Comparison with Peers NOTIFY PRESCRIBERS OF RESULTS · Individuals or Groups · Letters or Patient Notes or in Person Framework for Changing Drug Use Practices

Regulatory Options GOAL: To Restrict Decisions Market Controls Limiting Drug Registration Banning Previously Registered Drugs Rx - only to OTC Controlling Content in Drug Advertising Prescribing and Dispensing Controls Limiting Drugs Supplied in Public Sector Restricting Specific Drugs to Higher Levels of Care Required Generic Prescribing Allowing Generic Substitution Limits on Number or Quantity of Drugs per Patient Framework for Changing Drug Use Practices